tiprankstipranks
Icu Medical (ICUI)
NASDAQ:ICUI
US Market

ICU Medical (ICUI) Earnings Dates, Call Summary & Reports

Compare
191 Followers

Earnings Data

Report Date
May 12, 2025
TBA Not Confirmed
Period Ending
2025 (Q1)
Consensus EPS Forecast
1.27
Last Year’s EPS
0.96
Same Quarter Last Year
Moderate Buy
Based on 3 Analysts Ratings
---

Earnings Call Summary

Earnings Call Date:Feb 27, 2025
|
% Change Since: -5.88%
|
Next Earnings Date:May 12, 2025
Earnings Call Sentiment|Neutral
ICU Medical's earnings call presented a mixed picture. While the company experienced strong revenue growth and made significant progress in quality remediation and strategic partnerships, it faced challenges with declining gross margins, currency fluctuations, and potential tariff impacts. Operational adjustments were necessary due to the IV Solutions crisis, although the company managed to stabilize the situation.
Company Guidance
During the ICU Medical, Inc. Fourth Quarter 2024 Earnings Conference Call held on February 27, 2025, the company provided guidance for 2025, projecting consolidated adjusted revenue growth on a constant currency basis in the low-to-mid single-digit range. They anticipated adjusted gross margin to rise to 37%-38%, compared to 36% in 2024. Adjusted operating expenses were expected to be around 24% of revenue, reflecting a 3% increase from the previous year. Net interest expense was forecasted at approximately $95 million, with an adjusted tax rate around 25%. Diluted shares outstanding were estimated at 24.7 million. The company projected adjusted EBITDA between $395 million and $425 million, and adjusted EPS between $6.55 and $7.25. ICU Medical also discussed the impact of their joint venture transaction with Otsuka Pharmaceutical Factory, expected to close in the second quarter of 2025, which would deconsolidate the IV Solutions business and result in a reduction of $350 million in adjusted revenue and $25 million in adjusted EBITDA annually.
Strong Revenue Growth in Q4
ICU Medical reported Q4 revenue of $622 million, growing 9% on a constant currency basis or 8% reported, aided by a temporary shortage in IV Solutions. All three reporting segments experienced year-over-year growth.
Record Performance in Vital Care Segment
Vital Care segment grew 16% on a constant currency and reported basis, driven by a national shortage in IV Solutions. The shortage environment is expected to normalize midway through Q1 of 2025.
Significant Improvement in Adjusted EBITDA
Adjusted EBITDA for Q4 increased by 22% to $106 million, compared to $86 million in the previous year.
Positive Progress on Quality Remediation
ICU Medical achieved a successful FDA inspection at the site underpinning their warning letter, indicating progress in quality remediation efforts.
Strategic Joint Venture with Otsuka
ICU Medical announced a joint venture with Otsuka Pharmaceutical Factory to enhance the IV Solutions product line, expected to close in Q2 2025.
---

ICU Medical (ICUI) Earnings, Revenues Date & History

The upcoming earnings date is based on a company’s previous reporting, and may be updated when the actual date is announced

ICUI Earnings History

Report Date
Fiscal Quarter
Forecast / EPS
Last Year's EPS
EPS YoY Change
Press Release
Slides
Play Transcript
May 12, 20252025 (Q1)
1.27 / -
0.96
Feb 27, 20252024 (Q4)
1.48 / 2.11
1.5734.39% (+0.54)
Nov 12, 20242024 (Q3)
1.25 / 1.59
1.571.27% (+0.02)
Aug 07, 20242024 (Q2)
1.00 / 1.56
1.88-17.02% (-0.32)
May 07, 20242024 (Q1)
0.82 / 0.96
1.74-44.83% (-0.78)
Feb 27, 20242023 (Q4)
1.19 / 1.57
1.6-1.88% (-0.03)
Nov 06, 20232023 (Q3)
1.39 / 1.57
1.75-10.29% (-0.18)
Aug 07, 20232023 (Q2)
1.60 / 1.88
1.3737.23% (+0.51)
May 08, 20232023 (Q1)
1.43 / 1.74
1.82-4.40% (-0.08)
Feb 27, 20232022 (Q4)
1.56 / 1.60
1.82-12.09% (-0.22)
The table shows recent earnings report dates and whether the forecast was beat or missed. See the change in forecast and EPS from the previous year.
Beat
Missed
---

ICUI Earnings-Related Price Changes

Report Date
Price 1 Day Before
Price 1 Day After
Percentage Change
Feb 27, 2025$149.75$146.33-2.28%
Nov 12, 2024$178.01$174.81-1.80%
Aug 07, 2024$121.79$151.35+24.27%
May 07, 2024$101.77$100.60-1.15%
Earnings announcements can affect a stock’s price. This table shows the stock's price the day before and the day after recent earnings reports, including the percentage change.
---

FAQ

When does Icu Medical (ICUI) report earnings?
Icu Medical (ICUI) is schdueled to report earning on May 12, 2025, TBA Not Confirmed.
    What is Icu Medical (ICUI) earnings time?
    Icu Medical (ICUI) earnings time is at May 12, 2025, TBA Not Confirmed.
      Where can I see when companies are reporting earnings?
      You can see which companies are reporting today on our designated earnings calendar.
        What companies are reporting earnings today?
        You can see a list of the companies which are reporting today on TipRanks earnings calendar.
          What is ICUI EPS forecast?
          ICUI EPS forecast for the fiscal quarter 2025 (Q1) is 1.27.
            ---
            What am I Missing?
            Make informed decisions based on Top Analysts' activity
            Know what industry insiders are buying
            Get actionable alerts from top Wall Street Analysts
            Find out before anyone else which stock is going to shoot up
            Get powerful stock screeners & detailed portfolio analysis